Table 1

Demographic characteristics of patients receiving 2- and 3-level posterolateral lumbar fusion.

Variables2-Level Fusion (N = 557)3-Level Fusion (N = 287)
Age, mean ± SD61.74 ± 12.0563.71 ± 11.57
Gender: men, n (%)277 (50.0%)128 (44.9%)
Race: White, n (%)482 (87.2%)264 (93.0%)
Body mass index, mean ± SD31.23 ± 6.6830.67 ± 6.44
Comorbidities, n (%)
 1 or 2 Comorbidities319 (57.3%)165 (57.5%)
 >2 Comorbidities153 (27.5%)87 (30.3%)
 Coronary artery disease99 (23.6%)53 (22.9%)
 Hypertension350 (62.8%)193 (67.2%)
 Congestive heart failure17 (3.1%)10 (3.5%)
 Chronic obstructive pulmonary disease31 (5.6%)10 (3.5%)
 Osteoporosis17 (4.1%)14 (6.1%)
 Diabetes142 (25.5%)72 (25.1%)
Active smoker, n (%)88 (15.8%)51 (17.8%)
Preoperative anticoagulation/antiplatelet usage, n (%)13 (3.1%)8 (3.5%)
Insurance, n (%)
 Private237 (42.5%)95 (33.1%)
 Medicare/Medicaid/Tenncare265 (47.6%)171 (59.6%)
 Veterans Affairs/Government (includes Tricare)38 (6.8%)15 (5.2%)
 Uninsured/not available7 (1.3%)3 (1.0%)
Currently employed, n (%)191 (34.4%)67 (23.3%)
Intend to return to work, n (%)183 (95.8%)59 (89.4%)
Preoperative ambulation, n (%)
 With assistance179 (32.3%)96 (33.4%)
 Independent371 (66.8%)189 (65.9%)
 Wheelchair bound5 (0.9%)2 (0.7%)
Duration of symptoms, n (%)
 <3 mo33 (7.6%)15 (6.5%)
 3–12 mo141 (32.4%)67 (29.1%)
 >12 mo261 (60.0%)148 (64.3%)
Diagnosis, n (%)
 Stenosis132 (24.0%)66 (23.6%)
 Herniated disc11 (2.0%)10 (3.6%)
 Fracture29 (5.3%)14 (5.0%)
 Deformity/scoliosis43 (7.8%)60 (21.4%)
 Spondylolisthesis280 (51.0%)97 (34.6%)
 Pseudarthrosis30 (5.5%)22 (7.9%)
 Other22 (4.0%)11 (4.0%)
Revision, n (%)214 (38.4%)135 (47.0%)
Reason for revision, n (%)
 Adjacent segment disease68 (38.4%)43 (38.4%)
 Pseudarthrosis/instrumentation failure34 (19.2%)30 (26.8%)
 Same level recurrent stenosis53 (29.9%)26 (23.2%)
 Same level recurrent disc herniation16 (9.0%)6 (5.4%)
 Other6 (3.4%)7 (6.3%)